Literature DB >> 2895111

Promoting activity of di(2-ethylhexyl)phthalate in rat liver foci bioassay.

D Oesterle1, E Deml.   

Abstract

The plasticizer DEHP but not DEHS exerted a weak promoting effect in a 12-week rat liver foci bioassay, using weanling female Sprague-Dawley rats. The effect was similar after doses of 200 and 500 mg/kg body weight, given 3 times weekly by gavage for 11 consecutive weeks after initiation with a single oral dose of 8 mg DEN/kg body weight. Lower doses were ineffective. The incidence of foci with deficiency in ATPase was enhanced about twice compared to rats treated with DEN only. The incidence of foci with expression of GGTase was not affected by DEHP treatment. The results match the findings with lifetime exposure studies, when liver tumors were found in rats and mice. The actual risk for man from environmental DEHP contamination seems to be low; the intake from highly contaminated food is calculated to be about 400-fold lower than the lowest effective dose in this study.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2895111     DOI: 10.1007/bf00417826

Source DB:  PubMed          Journal:  J Cancer Res Clin Oncol        ISSN: 0171-5216            Impact factor:   4.553


  20 in total

1.  Di(2-ethylhexyl) phthalate.

Authors: 
Journal:  IARC Monogr Eval Carcinog Risk Chem Hum       Date:  1982-05

2.  Dissimilar patterns of promotion by di(2-ethylhexyl)phthalate and phenobarbital of hepatocellular neoplasia initiated by diethylnitrosamine in B6C3F1 mice.

Authors:  J M Ward; J M Rice; D Creasia; P Lynch; C Riggs
Journal:  Carcinogenesis       Date:  1983-08       Impact factor: 4.944

3.  Investigation of the potential for binding of Di(2-ethylhexyl) phthalate (DEHP) and Di(2-ethylhexyl) adipate (DEHA) to liver DNA in vivo.

Authors:  A von Däniken; W K Lutz; R Jäckh; C Schlatter
Journal:  Toxicol Appl Pharmacol       Date:  1984-05       Impact factor: 4.219

4.  The carcinogenicity of dietary di(2-ethylhexyl) phthalate (DEHP) in Fischer 344 rats and B6C3F1 mice.

Authors:  W M Kluwe; J K Haseman; J F Douglas; J E Huff
Journal:  J Toxicol Environ Health       Date:  1982 Oct-Nov

5.  Carcinogenesis Bioassay of Di(2-ethylhexyl)phthalate (CAS No. 117-81-7) in F344 Rats and B6C3F1 Mice (Feed Studies).

Authors: 
Journal:  Natl Toxicol Program Tech Rep Ser       Date:  1982-03

6.  Lack of hepatic promotional activity by the peroxisomal proliferating hepatocarcinogen di(2-ethylhexyl)phthalate.

Authors:  J A Popp; L K Garvey; T E Hamm; J A Swenberg
Journal:  Carcinogenesis       Date:  1985-01       Impact factor: 4.944

7.  Comparative pharmacokinetics and subacute toxicity of di(2-ethylhexyl) phthalate (DEHP) in rats and marmosets: extrapolation of effects in rodents to man.

Authors:  C Rhodes; T C Orton; I S Pratt; P L Batten; H Bratt; S J Jackson; C R Elcombe
Journal:  Environ Health Perspect       Date:  1986-03       Impact factor: 9.031

8.  Comparison of hepatic peroxisome proliferative effect and its implication for hepatocarcinogenicity of phthalate esters, di(2-ethylhexyl) phthalate, and di(2-ethylhexyl) adipate with a hypolipidemic drug.

Authors:  J K Reddy; M K Reddy; M I Usman; N D Lalwani; M S Rao
Journal:  Environ Health Perspect       Date:  1986-03       Impact factor: 9.031

9.  Chemical industry voluntary test program for phthalate esters: health effects studies.

Authors:  B Astill; E Barber; A Lington; E Moran; A Mulholland; E Robinson; B Scheider
Journal:  Environ Health Perspect       Date:  1986-03       Impact factor: 9.031

10.  Concentration-dependent inhibition of development of GGT positive foci in rat liver by the environmental contaminant di(2-ethylhexyl) phthalate.

Authors:  A B DeAngelo; A E Queral; C T Garrett
Journal:  Environ Health Perspect       Date:  1985-05       Impact factor: 9.031

View more
  1 in total

Review 1.  Modes of action and species-specific effects of di-(2-ethylhexyl)phthalate in the liver.

Authors:  Ivan Rusyn; Jeffrey M Peters; Michael L Cunningham
Journal:  Crit Rev Toxicol       Date:  2006-05       Impact factor: 5.635

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.